Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in moderate and severe renal failure (CKD 3-4)
NCT02848508Phase 2Withdrawn
- Sponsor
- CHU Amiens-Picardie
- Start
- Mar 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by CHU Amiens-Picardie. Planned start Mar 2016; status: withdrawn.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02848508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02848508.